Product Images Clopidogrel

The image shows the impact of proton pump inhibitors (PPIs) on the exposure of Clopidogrel Active Metabolite with multiple doses of Clopidogrel 75mg alone or with PPIs. The mean and 90% confidence interval of the AUC of the active metabolite are presented for Dextansoprazole (60mg), Lansoprazole (30mg), Pastoprazole (40mg), and Omeprazole (80mg) over a period of 12 hours. It also shows changes relative to Clopidogrel administered alone.*

This is a descriptive figure illustrating the event rates of cardiovascular death, myocardial infarction, and stroke in the CURE Study. The figure shows the cumulative percentage of events over a period of 12 months of follow-up. The data compare the use of placebo with aspirin versus clopidogrel with aspirin. Other standard therapies were also used as appropriate. The event rate was significantly lower in the clopidogrel group with aspirin compared to the placebo with aspirin group.*

The text is describing the data presented in Figure 4 of the COMMIT study. The figure shows the cumulative event rates for death in patients who received either a placebo or clopidogrel treatment. All patients received aspirin. The data shows that the percentage of deaths before the first discharge was lower in the clopidogrel group (7.5%) compared to the placebo group (8.1%). The study found a 7% proportional risk reduction in the clopidogrel group compared to the placebo group, with a p-value of 0.03. The x-axis shows the days since randomization, up to 28 days.*

This is a description of figure 5 of the COMMIT study. The figure shows the cumulative event rates for the combined endpoint of re-infarction, stroke or death in the treated group receiving Tlopidogrel versus the placebo group. The placebo group had 2310 events (10.1%), while the Tlopidogrel group had 2121 events (9.2%). The figure also displays a mortality rate of 5%, 7 re-infarction cases, a stroke, and discharge. There was a 9% proportional reduction in the risk of events with Tlopidogrel (p-0.002). The graph represents the event rates in days since randomization, which was up to 28 days, and all treated patients received aspirin.*

The text describes a figure, specifically "Figure 7", which shows the incidence of fatal or non-fatal vascular events in the CAPRIE study. The cumulative event rate is shown as a percentage over time (measured in months of follow-up) and compared between a treatment with clopidogrel and a control group. The P-value is 0.043.*

Clopidogrel is a prescription-only medication that comes in the form of 100 film-coated tablets contained in a package with ten blister packs each of ten tablets. Each tablet contains 7,875 mg of clopidogrel bisulfate equivalent to 75 mg of clopidogrel base. The usual dosage is described in the package insert. The medication must be stored at 20 to 25 degrees Celsius with excursions permitted between 15 to 30 degrees Celsius, and protected from moisture. It must be kept out of reach of children, and should not be used if the blister is torn or broken. This medication is manufactured and distributed by American Health Packaging, Columbus, Ohio, and is packaged in NDG # 60505-0253.*

This text appears to be a list of different lots of Clopidogrel tablets in the USP formulation, with a strength of 75mg. Each lot has a unique identification code and an expiry date. Some of the codes have been incorrectly scanned as there seems to be typos in the text.*

This text describes a medication called "Clopidogrel" which comes in a package containing 30 tablets as identified by the National Drug Code (NDC) number 68084-752-25. Each tablet contains 392 mg of Clopidogrel Bisulfate equivalent to 300mg of Clopidogrel base. This medication is available only with a prescription and the accompanying medication guide should be given to each patient when dispensing. The package is to be stored between 20°C to 25°C (68°F to 77°F), with permissible excursions between 15°C to 30°C (59°F to 86°F) to protect from moisture. The packaging is from American Health Packaging, Columbus, Ohio 43217.*

This is a list of Clopidogrel Tablets, USP of 300mg dosage, with different LOT and EXPIRY numbers.*